◀ Back to XRCC5
PRKDC — XRCC5
Pathways - manually collected, often from reviews:
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
APLF (APLF)
→
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV/APLF complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4-APLF)
(modification, collaborate)
Iles et al., Mol Cell Biol 2007, Kanno et al., EMBO J 2007
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
APLF (APLF)
→
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4)
(modification, collaborate)
Iles et al., Mol Cell Biol 2007, Kanno et al., EMBO J 2007
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV/APLF complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4-APLF)
→
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4)
(modification, collaborate)
Iles et al., Mol Cell Biol 2007, Kanno et al., EMBO J 2007
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
PNKP (PNKP)
→
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV/PNKP complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4-PNKP)
(modification, collaborate)
Koch et al., EMBO J 2004, Williams et al., Biochem Cell Biol 2005
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
PNKP (PNKP)
→
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4)
(modification, collaborate)
Koch et al., EMBO J 2004, Williams et al., Biochem Cell Biol 2005
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV/PNKP complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4-PNKP)
→
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4)
(modification, collaborate)
Koch et al., EMBO J 2004, Williams et al., Biochem Cell Biol 2005
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database BARD1 signaling events:
BARD1/DNA-PK/p53 complex (TP53-BARD1-PRKDC-XRCC6-XRCC5)
→
p53 (TP53)
(modification, collaborate)
-
NCI Pathway Database BARD1 signaling events:
BARD1/DNA-PK/p53 complex (TP53-BARD1-PRKDC-XRCC6-XRCC5)
→
BARD1/DNA-PK complex (BARD1-PRKDC-XRCC6-XRCC5)
(modification, collaborate)
-
NCI Pathway Database BARD1 signaling events:
p53 (TP53)
→
BARD1/DNA-PK complex (BARD1-PRKDC-XRCC6-XRCC5)
(modification, collaborate)
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
XRCC4 (dimer)/Ligase IV complex (XRCC4-LIG4)
→
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4)
(modification, collaborate)
Nick McElhinny et al., Mol Cell Biol 2000, Chen et al., J Biol Chem 2000, Mahajan et al., Mol Cell Biol 2002, Nick McElhinny et al., Mol Cell Biol 2003, Modesti et al., J Mol Biol 2003, Drouet et al., J Biol Chem 2005, Ma et al., Mol Cell 2004, Costantini et al., DNA repair 2007, Gu et al., EMBO J 2007, Li et al., Cell 1995, Grawunder et al., Nature 1997, Leber et al., J Biol Chem 1998
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
XRCC4 (dimer)/Ligase IV complex (XRCC4-LIG4)
→
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM)
(modification, collaborate)
Nick McElhinny et al., Mol Cell Biol 2000, Chen et al., J Biol Chem 2000, Mahajan et al., Mol Cell Biol 2002, Nick McElhinny et al., Mol Cell Biol 2003, Modesti et al., J Mol Biol 2003, Drouet et al., J Biol Chem 2005, Ma et al., Mol Cell 2004, Costantini et al., DNA repair 2007, Gu et al., EMBO J 2007, Li et al., Cell 1995, Grawunder et al., Nature 1997, Leber et al., J Biol Chem 1998
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4)
→
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM)
(modification, collaborate)
Nick McElhinny et al., Mol Cell Biol 2000, Chen et al., J Biol Chem 2000, Mahajan et al., Mol Cell Biol 2002, Nick McElhinny et al., Mol Cell Biol 2003, Modesti et al., J Mol Biol 2003, Drouet et al., J Biol Chem 2005, Ma et al., Mol Cell 2004, Costantini et al., DNA repair 2007, Gu et al., EMBO J 2007, Li et al., Cell 1995, Grawunder et al., Nature 1997, Leber et al., J Biol Chem 1998
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Artemis/DNA-PKcs complex (DCLRE1C-PRKDC)
→
KU complex (XRCC6-XRCC5)
(modification, collaborate)
Calsou et al., J Biol Chem 1999*, Ma et al., Cell 2002*, DeFazio et al., EMBO J 2002*, Dvir et al., Proc Natl Acad Sci U S A 1992*, Falck et al., Nature 2005, Rivera-Calzada et al., EMBO Rep 2007*, Uematsu et al., J Cell Biol 2007*, Williams et al., Structure 2008*, Suwa et al., Proc Natl Acad Sci U S A 1994*, Gottlieb et al., Cell 1993, Yaneva et al., EMBO J 1997*, Dynan et al., Nucleic Acids Res 1998*
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Artemis/DNA-PKcs complex (DCLRE1C-PRKDC)
→
Ku/Artemis/DNA-PKcs complex (XRCC6-XRCC5-DCLRE1C-PRKDC)
(modification, collaborate)
Calsou et al., J Biol Chem 1999*, Ma et al., Cell 2002*, DeFazio et al., EMBO J 2002*, Dvir et al., Proc Natl Acad Sci U S A 1992*, Falck et al., Nature 2005, Rivera-Calzada et al., EMBO Rep 2007*, Uematsu et al., J Cell Biol 2007*, Williams et al., Structure 2008*, Suwa et al., Proc Natl Acad Sci U S A 1994*, Gottlieb et al., Cell 1993, Yaneva et al., EMBO J 1997*, Dynan et al., Nucleic Acids Res 1998*
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
KU complex (XRCC6-XRCC5)
→
Ku/Artemis/DNA-PKcs complex (XRCC6-XRCC5-DCLRE1C-PRKDC)
(modification, collaborate)
Calsou et al., J Biol Chem 1999*, Ma et al., Cell 2002*, DeFazio et al., EMBO J 2002*, Dvir et al., Proc Natl Acad Sci U S A 1992*, Falck et al., Nature 2005, Rivera-Calzada et al., EMBO Rep 2007*, Uematsu et al., J Cell Biol 2007*, Williams et al., Structure 2008*, Suwa et al., Proc Natl Acad Sci U S A 1994*, Gottlieb et al., Cell 1993, Yaneva et al., EMBO J 1997*, Dynan et al., Nucleic Acids Res 1998*
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
None
→
Ku/Artemis/DNA-PKcs (dimer) complex (XRCC6-XRCC5-DCLRE1C-PRKDC)
(modification, collaborate)
Hanakahi et al., Cell 2000*, Hanakahi et al., EMBO J 2002*
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
None
→
Ku/Artemis/DNA-PKcs (dimer)IP6 complex (XRCC6-XRCC5-DCLRE1C-PRKDC)
(modification, collaborate)
Hanakahi et al., Cell 2000*, Hanakahi et al., EMBO J 2002*
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Ku/Artemis/DNA-PKcs (dimer) complex (XRCC6-XRCC5-DCLRE1C-PRKDC)
→
Ku/Artemis/DNA-PKcs (dimer)IP6 complex (XRCC6-XRCC5-DCLRE1C-PRKDC)
(modification, collaborate)
Hanakahi et al., Cell 2000*, Hanakahi et al., EMBO J 2002*
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
XRCC4 (dimer)/Ligase IV complex (XRCC4-LIG4)
→
Ku/Artemis/DNA-PKcs (dimer)/DNTT complex (XRCC6-XRCC5-DCLRE1C-PRKDC-DNTT)
(modification, collaborate)
Nick McElhinny et al., Mol Cell Biol 2000, Chen et al., J Biol Chem 2000, Mahajan et al., Mol Cell Biol 2002, Modesti et al., J Mol Biol 2003, Drouet et al., J Biol Chem 2005, Costantini et al., DNA repair 2007, Li et al., Cell 1995, Grawunder et al., Nature 1997, Leber et al., J Biol Chem 1998
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
XRCC4 (dimer)/Ligase IV complex (XRCC4-LIG4)
→
Ku/Artemis/DNA-PKcs (dimer)/DNTT/XRCC4 (dimer)/Ligase IV complex (XRCC6-XRCC5-DCLRE1C-PRKDC-DNTT-XRCC4-LIG4)
(modification, collaborate)
Nick McElhinny et al., Mol Cell Biol 2000, Chen et al., J Biol Chem 2000, Mahajan et al., Mol Cell Biol 2002, Modesti et al., J Mol Biol 2003, Drouet et al., J Biol Chem 2005, Costantini et al., DNA repair 2007, Li et al., Cell 1995, Grawunder et al., Nature 1997, Leber et al., J Biol Chem 1998
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Ku/Artemis/DNA-PKcs (dimer)/DNTT complex (XRCC6-XRCC5-DCLRE1C-PRKDC-DNTT)
→
Ku/Artemis/DNA-PKcs (dimer)/DNTT/XRCC4 (dimer)/Ligase IV complex (XRCC6-XRCC5-DCLRE1C-PRKDC-DNTT-XRCC4-LIG4)
(modification, collaborate)
Nick McElhinny et al., Mol Cell Biol 2000, Chen et al., J Biol Chem 2000, Mahajan et al., Mol Cell Biol 2002, Modesti et al., J Mol Biol 2003, Drouet et al., J Biol Chem 2005, Costantini et al., DNA repair 2007, Li et al., Cell 1995, Grawunder et al., Nature 1997, Leber et al., J Biol Chem 1998
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Pol Mu (POLM)
→
Ku/Artemis/DNA-PKcs (dimer) complex (XRCC6-XRCC5-DCLRE1C-PRKDC)
(modification, collaborate)
Mahajan et al., Mol Cell Biol 2002, Nick McElhinny et al., Mol Cell Biol 2003, Ma et al., Mol Cell 2004, Nick McElhinny et al., Mol Cell 2005, Davis et al., Nucleic Acids Res 2008
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Pol Mu (POLM)
→
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM)
(modification, collaborate)
Mahajan et al., Mol Cell Biol 2002, Nick McElhinny et al., Mol Cell Biol 2003, Ma et al., Mol Cell 2004, Nick McElhinny et al., Mol Cell 2005, Davis et al., Nucleic Acids Res 2008
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Ku/Artemis/DNA-PKcs (dimer) complex (XRCC6-XRCC5-DCLRE1C-PRKDC)
→
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM)
(modification, collaborate)
Mahajan et al., Mol Cell Biol 2002, Nick McElhinny et al., Mol Cell Biol 2003, Ma et al., Mol Cell 2004, Nick McElhinny et al., Mol Cell 2005, Davis et al., Nucleic Acids Res 2008
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Aprataxin (APTX)
→
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV/Aprataxin complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4-APTX)
(modification, collaborate)
Clements et al., DNA repair 2004, Ahel et al., Nature 2006
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Aprataxin (APTX)
→
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4)
(modification, collaborate)
Clements et al., DNA repair 2004, Ahel et al., Nature 2006
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV/Aprataxin complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4-APTX)
→
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4)
(modification, collaborate)
Clements et al., DNA repair 2004, Ahel et al., Nature 2006
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
POLL (POLL)
→
Ku/Artemis/DNA-PKcs (dimer)/POLL complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLL)
(modification, collaborate)
Lee et al., J Biol Chem 2004, Ma et al., Mol Cell 2004, Nick McElhinny et al., Mol Cell 2005
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
POLL (POLL)
→
Ku/Artemis/DNA-PKcs (dimer) complex (XRCC6-XRCC5-DCLRE1C-PRKDC)
(modification, collaborate)
Lee et al., J Biol Chem 2004, Ma et al., Mol Cell 2004, Nick McElhinny et al., Mol Cell 2005
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Ku/Artemis/DNA-PKcs (dimer)/POLL complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLL)
→
Ku/Artemis/DNA-PKcs (dimer) complex (XRCC6-XRCC5-DCLRE1C-PRKDC)
(modification, collaborate)
Lee et al., J Biol Chem 2004, Ma et al., Mol Cell 2004, Nick McElhinny et al., Mol Cell 2005
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
0005956 ()
→
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4)
(modification, activates)
Clements et al., DNA repair 2004, Koch et al., EMBO J 2004, Iles et al., Mol Cell Biol 2007, Kanno et al., EMBO J 2007
Evidence: mutant phenotype, assay
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
DNTT (DNTT)
→
Ku/Artemis/DNA-PKcs (dimer) complex (XRCC6-XRCC5-DCLRE1C-PRKDC)
(modification, collaborate)
Mickelsen et al., J Immunol 1999, Mahajan et al., Mol Cell Biol 2002
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
DNTT (DNTT)
→
Ku/Artemis/DNA-PKcs (dimer)/DNTT complex (XRCC6-XRCC5-DCLRE1C-PRKDC-DNTT)
(modification, collaborate)
Mickelsen et al., J Immunol 1999, Mahajan et al., Mol Cell Biol 2002
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Ku/Artemis/DNA-PKcs (dimer) complex (XRCC6-XRCC5-DCLRE1C-PRKDC)
→
Ku/Artemis/DNA-PKcs (dimer)/DNTT complex (XRCC6-XRCC5-DCLRE1C-PRKDC-DNTT)
(modification, collaborate)
Mickelsen et al., J Immunol 1999, Mahajan et al., Mol Cell Biol 2002
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV/XLF (dimer) complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4-NHEJ1)
→
XLF (dimer) complex (NHEJ1)
(modification, collaborate)
Ahnesorg et al., Cell 2006, Callebaut et al., J Biol Chem 2006, Tsai et al., Proc Natl Acad Sci U S A 2007, Gu et al., Nucleic Acids Res 2007, Li et al., EMBO J 2008, Andres et al., Mol Cell 2007
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV/XLF (dimer) complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4-NHEJ1)
→
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4)
(modification, collaborate)
Ahnesorg et al., Cell 2006, Callebaut et al., J Biol Chem 2006, Tsai et al., Proc Natl Acad Sci U S A 2007, Gu et al., Nucleic Acids Res 2007, Li et al., EMBO J 2008, Andres et al., Mol Cell 2007
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
XLF (dimer) complex (NHEJ1)
→
Ku/Artemis/DNA-PKcs (dimer)/Pol Mu/XRCC4 (dimer)/Ligase IV complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLM-XRCC4-LIG4)
(modification, collaborate)
Ahnesorg et al., Cell 2006, Callebaut et al., J Biol Chem 2006, Tsai et al., Proc Natl Acad Sci U S A 2007, Gu et al., Nucleic Acids Res 2007, Li et al., EMBO J 2008, Andres et al., Mol Cell 2007
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database Coregulation of Androgen receptor activity:
DNA-PK complex (PRKDC-XRCC5-XRCC6)
→
AR/T-DHT complex (AR)
(transcription, activates)
Mayeur et al., J Biol Chem 2005
Evidence: mutant phenotype, reporter gene
-
NCI Pathway Database BARD1 signaling events:
BARD1 (BARD1)
→
DNA-PK complex (PRKDC-XRCC5-XRCC6)
(modification, collaborate)
Feki et al., Oncogene 2005
Evidence: assay, physical interaction
-
NCI Pathway Database BARD1 signaling events:
BARD1 (BARD1)
→
BARD1/DNA-PK complex (BARD1-PRKDC-XRCC6-XRCC5)
(modification, collaborate)
Feki et al., Oncogene 2005
Evidence: assay, physical interaction
-
NCI Pathway Database BARD1 signaling events:
DNA-PK complex (PRKDC-XRCC5-XRCC6)
→
BARD1/DNA-PK complex (BARD1-PRKDC-XRCC6-XRCC5)
(modification, collaborate)
Feki et al., Oncogene 2005
Evidence: assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Ku/Artemis/DNA-PKcs (dimer)/POLL complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLL)
→
XRCC4 (dimer)/Ligase IV complex (XRCC4-LIG4)
(modification, collaborate)
Nick McElhinny et al., Mol Cell Biol 2000, Chen et al., J Biol Chem 2000, Lee et al., J Biol Chem 2004, Modesti et al., J Mol Biol 2003, Drouet et al., J Biol Chem 2005, Ma et al., Mol Cell 2004, Costantini et al., DNA repair 2007, Gu et al., EMBO J 2007, Li et al., Cell 1995, Grawunder et al., Nature 1997, Leber et al., J Biol Chem 1998
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Ku/Artemis/DNA-PKcs (dimer)/POLL complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLL)
→
Ku/Artemis/DNA-PKcs (dimer)/POLL/XRCC4 (dimer)/Ligase IV complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLL-XRCC4-LIG4)
(modification, collaborate)
Nick McElhinny et al., Mol Cell Biol 2000, Chen et al., J Biol Chem 2000, Lee et al., J Biol Chem 2004, Modesti et al., J Mol Biol 2003, Drouet et al., J Biol Chem 2005, Ma et al., Mol Cell 2004, Costantini et al., DNA repair 2007, Gu et al., EMBO J 2007, Li et al., Cell 1995, Grawunder et al., Nature 1997, Leber et al., J Biol Chem 1998
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
XRCC4 (dimer)/Ligase IV complex (XRCC4-LIG4)
→
Ku/Artemis/DNA-PKcs (dimer)/POLL/XRCC4 (dimer)/Ligase IV complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLL-XRCC4-LIG4)
(modification, collaborate)
Nick McElhinny et al., Mol Cell Biol 2000, Chen et al., J Biol Chem 2000, Lee et al., J Biol Chem 2004, Modesti et al., J Mol Biol 2003, Drouet et al., J Biol Chem 2005, Ma et al., Mol Cell 2004, Costantini et al., DNA repair 2007, Gu et al., EMBO J 2007, Li et al., Cell 1995, Grawunder et al., Nature 1997, Leber et al., J Biol Chem 1998
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
XLF (dimer) complex (NHEJ1)
→
Ku/Artemis/DNA-PKcs (dimer)/POLL/XRCC4 (dimer)/Ligase IV/XLF (dimer) complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLL-XRCC4-LIG4-NHEJ1)
(modification, collaborate)
Ahnesorg et al., Cell 2006, Callebaut et al., J Biol Chem 2006, Tsai et al., Proc Natl Acad Sci U S A 2007, Gu et al., Nucleic Acids Res 2007, Li et al., EMBO J 2008, Andres et al., Mol Cell 2007
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
XLF (dimer) complex (NHEJ1)
→
Ku/Artemis/DNA-PKcs (dimer)/POLL/XRCC4 (dimer)/Ligase IV complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLL-XRCC4-LIG4)
(modification, collaborate)
Ahnesorg et al., Cell 2006, Callebaut et al., J Biol Chem 2006, Tsai et al., Proc Natl Acad Sci U S A 2007, Gu et al., Nucleic Acids Res 2007, Li et al., EMBO J 2008, Andres et al., Mol Cell 2007
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Ku/Artemis/DNA-PKcs (dimer)/POLL/XRCC4 (dimer)/Ligase IV/XLF (dimer) complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLL-XRCC4-LIG4-NHEJ1)
→
Ku/Artemis/DNA-PKcs (dimer)/POLL/XRCC4 (dimer)/Ligase IV complex (XRCC6-XRCC5-DCLRE1C-PRKDC-POLL-XRCC4-LIG4)
(modification, collaborate)
Ahnesorg et al., Cell 2006, Callebaut et al., J Biol Chem 2006, Tsai et al., Proc Natl Acad Sci U S A 2007, Gu et al., Nucleic Acids Res 2007, Li et al., EMBO J 2008, Andres et al., Mol Cell 2007
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database DNA-PK pathway in nonhomologous end joining:
Ku/Artemis/DNA-PKcs complex (XRCC6-XRCC5-DCLRE1C-PRKDC)
→
Ku/Artemis/DNA-PKcs (dimer) complex (XRCC6-XRCC5-DCLRE1C-PRKDC)
(modification, collaborate)
Calsou et al., J Biol Chem 1999*, Ma et al., Cell 2002*, DeFazio et al., EMBO J 2002*, Douglas et al., Biochem J 2002, Chan et al., Genes Dev 2002, Soubeyrand et al., Cancer Res 2003*, Weterings et al., Nucleic Acids Res 2003*, Reddy et al., J Biol Chem 2004*, Block et al., Nucleic Acids Res 2004*, Ma et al., DNA repair 2005*, Cui et al., Mol Cell Biol 2005*, Goodarzi et al., EMBO J 2006*, Meek et al., Mol Cell Biol 2007*, Uematsu et al., J Cell Biol 2007*, Povirk et al., Nucleic Acids Res 2007*, Yannone et al., Nucleic Acids Res 2008*
Evidence: mutant phenotype, assay, physical interaction
-
Reactome Reaction:
XRCC5
→
PRKDC
(reaction)
Kurimasa et al., Mol Cell Biol 1999, Yoo et al., Nucleic Acids Res 1999*, Kienker et al., Nucleic Acids Res 2000, Douglas et al., J Biol Chem 2001, Douglas et al., Biochem J 2002, Chan et al., Genes Dev 2002, Merkle et al., Biochemistry 2002, Ding et al., Mol Cell Biol 2003, Zhang et al., J Immunol 2011*, Ferguson et al., eLife 2012*, Gottlieb et al., Cell 1993, Chan et al., J Biol Chem 1996, Baumann et al., Proc Natl Acad Sci U S A 1998
-
Reactome Reaction:
XRCC5
→
PRKDC
(indirect_complex)
Yoo et al., Nucleic Acids Res 1999*, Inamdar et al., J Biol Chem 2002*, Zhang et al., J Immunol 2011*, Ferguson et al., eLife 2012*, Gottlieb et al., Cell 1993
-
Reactome Reaction:
XRCC5
→
PRKDC
(direct_complex)
Critchlow et al., Curr Biol 1997*, Leber et al., J Biol Chem 1998
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
-
IRef Bind Interaction:
PRKDC
—
XRCC5
Falck et al., Nature 2005
-
IRef Bind Interaction:
Complex of HDLBP-XRCC6-PRKDC-XRCC5
Walker et al., Nature 2001*, Wang et al., Curr Biol 2005
-
IRef Bind_translation Interaction:
PRKDC
—
XRCC5
(coimmunoprecipitation)
Falck et al., Nature 2005
-
IRef Bind_translation Interaction:
PRKDC
—
XRCC5
(affinity chromatography technology)
Falck et al., Nature 2005
-
IRef Biogrid Interaction:
XRCC5
—
PRKDC
(physical association, affinity chromatography technology)
Sand-Dejmek et al., Molecular cancer 2011
-
IRef Biogrid Interaction:
XRCC5
—
PRKDC
(direct interaction, enzymatic study)
Sartorius et al., J Mol Endocrinol 2000*
-
IRef Biogrid Interaction:
XRCC5
—
PRKDC
(physical association, affinity chromatography technology)
Drouet et al., J Biol Chem 2006*
-
IRef Biogrid Interaction:
XRCC5
—
PRKDC
(association, x-ray crystallography)
Sibanda et al., Nature 2010*
-
IRef Biogrid Interaction:
XRCC5
—
PRKDC
(direct interaction, pull down)
Jin et al., J Biol Chem 1997*
-
IRef Biogrid Interaction:
XRCC5
—
PRKDC
(physical association, affinity chromatography technology)
Matheos et al., Biochim Biophys Acta 2002
-
IRef Biogrid Interaction:
XRCC5
—
PRKDC
(direct interaction, pull down)
Gell et al., Nucleic Acids Res 1999*
-
IRef Biogrid Interaction:
XRCC5
—
PRKDC
(physical association, affinity chromatography technology)
Drouet et al., J Biol Chem 2005
-
IRef Biogrid Interaction:
XRCC5
—
PRKDC
(physical association, affinity chromatography technology)
Falck et al., Nature 2005
-
IRef Biogrid Interaction:
XRCC5
—
PRKDC
(direct interaction, pull down)
Falck et al., Nature 2005
-
IRef Biogrid Interaction:
XRCC5
—
PRKDC
(physical association, affinity chromatography technology)
Olsen et al., BMC molecular biology 2012
-
IRef Biogrid Interaction:
XRCC5
—
PRKDC
(colocalization, imaging technique)
Olsen et al., BMC molecular biology 2012
-
MIPS CORUM Vigilin-DNA-PK-Ku antigen complex:
Vigilin-DNA-PK-Ku antigen complex complex (HDLBP-PRKDC-XRCC5-XRCC6)
Wang et al., Curr Biol 2005
-
MIPS CORUM DHX9-ADAR-vigilin-DNA-PK-Ku antigen complex:
DHX9-ADAR-vigilin-DNA-PK-Ku antigen complex complex (ADAR-DHX9-HDLBP-PRKDC-XRCC5-XRCC6)
Wang et al., Curr Biol 2005
-
MIPS CORUM DNA-PK-Ku complex:
DNA-PK-Ku complex complex (PRKDC-XRCC5-XRCC6)
Spagnolo et al., Mol Cell 2006*
-
MIPS CORUM DNA-PK-Ku antigen complex:
DNA-PK-Ku antigen complex complex (PRKDC-XRCC5-XRCC6)
Dvir et al., Proc Natl Acad Sci U S A 1992*
-
MIPS CORUM DNA-PK-Ku antigen complex:
DNA-PK-Ku antigen complex complex (PRKDC-XRCC5-XRCC6)
Gottlieb et al., Cell 1993
-
MIPS CORUM DNA-PK-Ku antigen complex:
DNA-PK-Ku antigen complex complex (PRKDC-XRCC5-XRCC6)
Dvir et al., J Biol Chem 1993*
-
MIPS CORUM MGC1-DNA-PKcs-Ku complex:
MGC1-DNA-PKcs-Ku complex complex (MDC1-PRKDC-XRCC5-XRCC6)
Lou et al., J Biol Chem 2004*
-
MIPS CORUM NCOA6-DNA-PK-Ku-PARP1 complex:
NCOA6-DNA-PK-Ku-PARP1 complex complex (NCOA6-PARP1-PRKDC-XRCC5-XRCC6)
Ko et al., J Biol Chem 2003
-
MIPS CORUM DNA-PK-Ku complex:
DNA-PK-Ku complex complex (PRKDC-XRCC5-XRCC6)
Ting et al., J Biol Chem 1998
-
MIPS CORUM DNA-PK-Ku-eIF2-NF90-NF45 complex:
DNA-PK-Ku-eIF2-NF90-NF45 complex complex (EIF2S1-EIF2S2-EIF2S3-ILF2-ILF3-PRKDC-XRCC5-XRCC6)
Ting et al., J Biol Chem 1998
-
IRef Corum Interaction:
Complex of NCOA6-PRKDC-XRCC5-XRCC6-PARP1
(association, pull down)
Ko et al., J Biol Chem 2003
-
IRef Corum Interaction:
Complex of 22 proteins
(association, electrophoretic mobility supershift assay)
Ting et al., J Biol Chem 1998
-
IRef Corum Interaction:
Complex of XRCC6-HDLBP-PRKDC-XRCC5-ADAR-DHX9
(association, anti tag coimmunoprecipitation)
Wang et al., Curr Biol 2005
-
IRef Corum Interaction:
Complex of 17 proteins
(association, electrophoretic mobility supershift assay)
Ting et al., J Biol Chem 1998
-
IRef Corum Interaction:
Complex of XRCC6-XRCC6-XRCC5-XRCC5-PRKDC-PRKDC-MDC1-MDC1
(association, pull down)
Lou et al., J Biol Chem 2004*
-
IRef Corum Interaction:
Complex of XRCC6-XRCC5-PRKDC-HDLBP
(association, anti tag coimmunoprecipitation)
Wang et al., Curr Biol 2005
-
IRef Dip Interaction:
Complex of 21 proteins
(tandem affinity purification)
Shuaib et al., Proc Natl Acad Sci U S A 2010
-
IRef Dip Interaction:
Complex of 19 proteins
(tandem affinity purification)
Shuaib et al., Proc Natl Acad Sci U S A 2010
-
IRef Dip Interaction:
PRKDC
—
XRCC5
(direct interaction, x-ray crystallography)
Sibanda et al., Nature 2010*
-
Gene Ontology Complexes nonhomologous end joining complex:
nonhomologous end joining complex complex (LIG4-PRKDC-XRCC5-XRCC4-XRCC6)
Roberts et al., Nature 2010*
-
IRef Hprd Interaction:
Complex of 51 proteins
(in vivo)
Rubin et al., Cancer Res 2007*
-
IRef Hprd Interaction:
Complex of 65 proteins
Wong et al., Cell 2009
-
IRef Hprd Interaction:
Complex of PRKDC-XRCC5-MDC1-XRCC5-PRKDC-MDC1-MDC1-PRKDC-XRCC5
(in vivo)
Lou et al., J Biol Chem 2004*
-
IRef Hprd Interaction:
Complex of 37 proteins
(in vivo)
Reichman et al., Mol Cell Biol 2002, Ting et al., J Biol Chem 1998
-
IRef Hprd Interaction:
Complex of 50 proteins
(in vivo)
Mayeur et al., J Biol Chem 2005
-
IRef Hprd Interaction:
XRCC5
—
PRKDC
(in vivo)
Singleton et al., Mol Cell Biol 1999*, Gell et al., Nucleic Acids Res 1999*, Jin et al., J Biol Chem 1997*
-
IRef Hprd Interaction:
XRCC5
—
PRKDC
(in vitro)
Singleton et al., Mol Cell Biol 1999*, Gell et al., Nucleic Acids Res 1999*, Jin et al., J Biol Chem 1997*
-
IRef Hprd Interaction:
Complex of 37 proteins
(in vivo)
Ko et al., J Biol Chem 2003
-
IRef Hprd Interaction:
Complex of 33 proteins
(in vivo)
Wang et al., Curr Biol 2005
-
IRef Intact Interaction:
Complex of 12 proteins
(association, pull down)
Kanno et al., EMBO J 2007
-
IRef Intact Interaction:
Complex of PARP1-ETS1-XRCC5-PRKDC-XRCC6
(association, anti tag coimmunoprecipitation)
Brenner et al., Cancer Cell 2011
-
IRef Intact Interaction:
Complex of XRCC6-PARP1-XRCC5-PRKDC-ETV1
(association, anti tag coimmunoprecipitation)
Brenner et al., Cancer Cell 2011
-
IRef Intact Interaction:
Complex of XRCC6-ERG-XRCC5-PRKDC
(association, anti bait coimmunoprecipitation)
Brenner et al., Cancer Cell 2011
-
IRef Intact Interaction:
Complex of XRCC5-ERG-XRCC6-PARP1-PRKDC
(association, anti tag coimmunoprecipitation)
Brenner et al., Cancer Cell 2011
-
IRef Intact Interaction:
Complex of 117 proteins
(association, tandem affinity purification)
Zhao et al., Journal of proteomics 2011
-
IRef Intact Interaction:
Complex of 222 proteins
(association, tandem affinity purification)
Koch et al., Cell cycle (Georgetown, Tex.) 2007
-
IRef Intact Interaction:
Complex of 60 proteins
(association, tandem affinity purification)
Zhao et al., Journal of proteomics 2011
-
IRef Intact Interaction:
Complex of 45 proteins
(association, anti tag coimmunoprecipitation)
Brenner et al., Cancer Cell 2011
-
IRef Intact Interaction:
Complex of 306 proteins
(association, pull down)
Komarova et al., Mol Cell Proteomics 2011
-
IRef Intact Interaction:
Complex of 248 proteins
(association, pull down)
von Eyss et al., EMBO J 2012
-
IRef Intact Interaction:
Complex of 11 proteins
(association, anti tag coimmunoprecipitation)
Wong et al., Cell 2009
-
IRef Intact Interaction:
PRKDC
—
XRCC5
(physical association, proximity ligation assay)
Olsen et al., Oncogene 2010*
-
IRef Intact Interaction:
Complex of PRKDC-XRCC5-XRCC6-PARP1-XRCC6-PARP1-XRCC5-PRKDC
(association, anti bait coimmunoprecipitation)
Brenner et al., Cancer Cell 2011
-
IRef Intact Interaction:
Complex of XRCC6-PRKDC-XRCC5-PARP1-ERG
(association, anti bait coimmunoprecipitation)
Brenner et al., Cancer Cell 2011
-
IRef Intact Interaction:
Complex of 16 proteins
(association, anti tag coimmunoprecipitation)
Abramson et al., Cell 2010
-
IRef Intact Interaction:
Complex of PARP1-PRKDC-XRCC5-XRCC6-SPI1
(association, anti tag coimmunoprecipitation)
Brenner et al., Cancer Cell 2011
-
IRef Intact Interaction:
Complex of TOP2B-PRKDC-USF1-KAT2B-PARP1-XRCC5
(physical association, anti bait coimmunoprecipitation)
Wong et al., Cell 2009
-
IRef Intact Interaction:
Complex of PARP1-PRKDC-TOP2A-XRCC5
(association, anti bait coimmunoprecipitation)
Abramson et al., Cell 2010
-
IRef Intact Interaction:
Complex of H2AFX-XRCC5-TOP2A-AIRE-PARP1-PRKDC
(association, anti bait coimmunoprecipitation)
Abramson et al., Cell 2010
-
IRef Intact Interaction:
Complex of 13 proteins
(association, pull down)
Rubin et al., Cancer Res 2007*
-
IRef Intact Interaction:
Complex of TOP2B-HDAC9-PRKDC-XRCC5-USF1-PARP1-XRCC6-KAT2B-USF2
(association, anti bait coimmunoprecipitation)
Wong et al., Cell 2009
-
IRef Intact Interaction:
Complex of ERG-PARP1-PRKDC-XRCC5
(association, anti bait coimmunoprecipitation)
Brenner et al., Cancer Cell 2011
-
IRef Intact Interaction:
Complex of XRCC5-XRCC6-PRKDC-USF1
(phosphorylation reaction, protein kinase assay)
Wong et al., Cell 2009
-
IRef Ophid Interaction:
PRKDC
—
XRCC5
(aggregation, confirmational text mining)
-
IRef Ophid Interaction:
PRKDC
—
XRCC5
(aggregation, interologs mapping)
Brown et al., Bioinformatics 2005
Text-mined interactions from Literome
Abraham et al., Oncogene 1999
:
Recent studies have indicated that
DNA-PK is not
required for the transactivation or apoptosis promoting activities of
p53 protein
Kachnic et al., J Biol Chem 1999
:
Taken together, these data suggest that loss of DNA-PK activity appears to attenuate the kinetics of p53 to activate downstream genes, implying that
DNA-PK plays a role in post-translational modification of
p53 , without affecting the increase in levels of p53 in response to DNA damage
Araki et al., Cancer Res 1999
(Mammary Neoplasms, Experimental) :
Furthermore, we identified a missense point mutation in the p53 DNA binding motif region in SCGR11 cells, which were established from severe combined immunodeficient ( SCID ) mice and used for previous study on the
role of
DNA-PK in
p53 transactivation
Ariumi et al., Oncogene 1999
:
Thus,
DNA-PK suppresses
PARP activity, probably through direct binding and/or sequestration of DNA-ends which serve as an important stimulator for both enzymes
Iftode et al., Crit Rev Biochem Mol Biol 1999
:
RPA is a phosphorylation
target for
DNA dependent protein kinase (DNA-PK) and likely the ataxia telangiectasia mutated gene (ATM) protein kinase, and recent observations are described that suggest that RPA phosphorylation plays a significant modulatory role in the cellular response to DNA damage
Lin et al., Mol Immunol 1999
:
These data raise the possibility that
DNA-PK mediated phosphorylation of the
RAG proteins could regulate the hairpin opening reaction
Brown et al., J Biol Chem 2000
:
Further, we uncovered that the postirradiation up-regulation of Ku70 utilizes a mechanism that is dependent on both p53 and damage response protein kinase ATM ( ataxia-telangiectasia mutated ) ; however, the activation of
DNA-PK does not
require Ku70 up-regulation
Shangary et al., J Biol Chem 2000
(Ataxia Telangiectasia) :
To unravel the
role of ATM and
DNA-PK in the activation of
Abl , we assayed Abl, ATM, and DNA-PK activity in ATM- and DNA-PKcs-deficient cells after irradiation ... Conversely, normal activation of both ATM and c-Abl occurs in DNA-PKcs-deficient cells, indicating that ATM but not
DNA-PK is
required for activation of
Abl in response to IR treatment ... Examination of DNA-PK activity in response to IR treatment in Abl-deficient cells expressing mutant forms of Abl or in normal cells exposed to an inhibitor of Abl suggests an in vivo
role for
Abl in the down-regulation of
DNA-PK activity
Sook Kim et al., Biochem Biophys Res Commun 2001
(Liver Neoplasms...) :
In addition, wortmannin, a DNA dependent protein kinase (DNA-PK) inhibitor, decreased the level of hHR21 ( SP ) mRNA, indicating that
DNA-PK might be
involved in the regulation of
hHR21 ( SP )
Bryntesson et al., Radiat Res 2001
:
We present evidence that transcription of the extracellular matrix gene
laminin alpha 4 (Lama4) is
regulated by
DNA-PK in a radiation independent manner
Burma et al., J Biol Chem 2001
:
The minimal H2AX phosphorylation in Atm-/- fibroblasts can be abolished by low concentrations of wortmannin suggesting that
DNA-PK , rather than ATR, is
responsible for low levels of
H2AX phosphorylation in the absence of ATM
Silins et al., Carcinogenesis 2001
(Liver Neoplasms...) :
An inhibitor of
DNA dependent protein kinase (DNA-PK) and ataxia telangiectasia mutated (ATM), wortmannin,
blocked the DEN induced
p53 response in non-EAF hepatocytes
Erdemir et al., J Cell Sci 2002
:
The nuclear matrix protein
C1D is an
activator of the
DNA dependent protein kinase (DNA-PK) , which is essential for the repair of DNA double-strand breaks ( DSBs ) and V ( D ) J recombination ... The nuclear matrix
protein C1D is an
activator of the DNA dependent protein kinase
(DNA-PK) , which is essential for the repair of DNA double-strand breaks ( DSBs ) and V ( D ) J recombination
Servant et al., Biochem Pharmacol 2002
(Virus Diseases) :
Furthermore, MAP kinase kinase kinase ( MAP KKK ) -related pathways and
DNA-PK induce N-terminal phosphorylation of
IRF-3
Marples et al., Int J Radiat Biol 2002
:
These data support a role for
DNA-PK activity in the
IRR response
Boldogh et al., Toxicology 2003
(Ovarian Neoplasms) :
The decreased kinase activity of DNA-PKcs was not due to a change in its amount or the levels of Ku70 and Ku86, their subcellular distribution, cell cycle progression or
caspase mediated degradation of
DNA-PK ... The decreased kinase activity of
DNA-PKcs was not
due to a change in its amount or the levels of Ku70 and
Ku86 , their subcellular distribution, cell cycle progression or caspase mediated degradation of DNA-PK ... The decreased kinase activity of
DNA-PKcs was not
due to a change in its amount or the levels of Ku70 and Ku86, their subcellular distribution, cell cycle progression or caspase mediated degradation of
DNA-PK
Schild-Poulter et al., Cancer Res 2003
:
Histone
H2B and U2 RNA, whose expression are highly dependent on Oct-1, were strongly decreased in response to ionizing radiation in a
DNA-PK dependent manner, and Oct-1 dependent reporter gene transcription was repressed ... Furthermore,
Oct-1 phosphorylation in response to ionizing radiation increased in a
DNA-PK dependent manner ... Paradoxically, down-regulation of transactivation correlated with the rapid
DNA-PK dependent stabilization of
Oct-1
Jack et al., J Biol Chem 2004
:
Using wortmannin, serine 15 mutants of p53, DNA-PK null cells and Chk2 null cells, we demonstrate that
DNA-PK and Chk2
act independently and sequentially on
p53
Block et al., Nucleic Acids Res 2004
:
However, the relative
roles of ATM and
DNA-PK in the site-specific DNA damage induced phosphorylation of
RPA32 have not been reported
Um et al., Exp Mol Med 2004
(Neoplasms) :
In this study, we revealed that
DNA dependent protein kinase (DNA-PK) , which plays a crucial role in DNA double strand break repair, would be
involved in regulation of
hypoxia inducible factor-1 (HIF-1)
Veuger et al., Oncogene 2004
:
Inactive
DNA-PK suppressed the activity of
PARP-1 and vice versa ... The inhibitory
effect of
DNA-PK on
PARP activity was confirmed in permeabilized cells
Soubeyrand et al., Eur J Biochem 2004
:
Our results suggest a
role for
DNA-PK in the modulation of
p53 activity resultant from the convergence of p53 and DNA-PK on structured DNA
Li et al., J Biol Chem 2005
:
Down-regulation of
DNA-PK ( cs ) by either siRNA or a chemical inhibitor
attenuated radiation induced
Chk2 phosphorylation
Dragoi et al., EMBO J 2005
:
Further in vitro analysis using purified DNA-PK and recombinant Akt proteins reveals that
DNA-PK directly
induces phosphorylation and activation of
Akt
Vidal et al., Thromb Haemost 2005
:
Here, we show that ATM and ATR kinases, but not
DNA-PK , which participate in DNA damage activated checkpoints,
regulate the phosphorylation of
p53 at serine 15 in response to MNNG cell treatment
Douglas et al., DNA repair 2005
:
DNA-PK dependent phosphorylation of
Ku70/80 is not required for non-homologous end joining ...
DNA-PK dependent phosphorylation of
Ku70/80 is not required for non-homologous end joining
Dittmann et al., J Biol Chem 2005
:
Blockade of EGFR import by the anti-EGFR monoclonal antibody C225 abolished
EGFR import into the nucleus and radiation induced
activation of
DNA-PK , inhibited DNA repair, and increased radiosensitivity of treated cells
Dittmann et al., Radiother Oncol 2005
:
Inhibition of radiation induced
EGFR nuclear import by C225 ( Cetuximab )
suppresses DNA-PK activity
Cowell et al., Biochem Pharmacol 2005
(Breast Neoplasms) :
ATM inhibition reduced the initial average intensity of gammaH2AX foci while inhibition of
DNA-PK had only a small effect on the initial phosphorylation of
H2AX
Chowdhury et al., Mol Cell 2005
:
The effect of PP2A on
gamma-H2AX levels is
independent of ATM, ATR, or
DNA-PK activity
Chin et al., Exp Mol Med 2005
(Neoplasms) :
We also revealed that the combined treatment of radiation and the inhibitor of
protein kinase A (PKA) to these radioresistant cells
resulted in synergistic inhibition of
DNA-PK , Rad51 and Bcl-2 expressions of the cells, and consequently restored radiosensitivity of the cells
Friedmann et al., Mol Cancer Ther 2006
(Neoplasms) :
In this study, we specifically investigated the
effect of
EGFR inhibition by gefitinib on functional activity of DNA-PK in cancer cell lines and the interaction between EGFR and
DNA-PK
Mukherjee et al., DNA repair 2006
:
Interestingly, we find here that
DNA dependent protein kinase (DNA-PK) is solely
responsible for
H2AX phosphorylation during apoptosis while ATM is dispensable for the process
Rossi et al., J Gen Virol 2006
:
It was also found that, in cell-free extracts, TCF-4 prevented
dsDNA dependent protein kinase (DNA-PK) mediated
Sp1 phosphorylation
Rodríguez-Bravo et al., Cancer Res 2006
:
Neither wortmannin, Ly294002, nor SB202190 abrogated the caffeine-insensitive checkpoint response, indicating that
DNA-PK and p38 alpha, beta are not
involved in the ATR/ATM independent
Chk1 activation upon DNA synthesis inhibition
Cobb et al., Cancer Res 2006
(Prostatic Neoplasms) :
In the absence of
DNA-PK activity,
IGFBP-3 has
reduced nuclear accumulation and is unable to bind its nuclear binding partner retinoid X receptor (RXR) alpha
Zhong et al., Biochemistry 2007
:
The indispensable role
played by
DNA-PK in
P-gp overexpression in MDR leukemia cells in this report identifies targeted DNA-PK inhibition as a rational strategy to reverse drug resistance in cancer
Ravi et al., Mol Cell Biochem 2008
(Melanoma) :
In addition, our study shows that ATM, but not ATM-Rad3 related (ATR) or
DNA dependent protein kinase (DNA-PK) is
involved in UV-induced
NF-kappaB activation
Liiv et al., Biochim Biophys Acta 2008
:
DNA-PK contributes to the phosphorylation of
AIRE : importance in transcriptional activity
Wanner et al., Radiother Oncol 2008
:
Nuclear
EGFR is
involved in phosphorylation of
DNA-PK at Thr2609, which has a significant impact upon DNA-DSB repair
Müller et al., J Cell Biol 2007
:
DNA-PK is activated during replication stress and DNA-PK signaling is
enhanced when
ATR/ATM signaling is abrogated
Arlander et al., Cancer Res 2008
:
Furthermore, in agreement with the checkpoint attenuation,
DNA-PK inhibition in ATM-knockdown cells
resulted in reduced signaling of the checkpoint kinase CHK1 as evidenced by reduced
CHK1 phosphorylation
Bozulic et al., Mol Cell 2008
:
PKB activation following DNA damage
requires 3-phosphoinositide dependent kinase 1 ( PDK1 ) and
DNA dependent protein kinase (DNA-PK)
Boehme et al., Proc Natl Acad Sci U S A 2008
:
Correspondingly, down-regulation of
DNA-PK prevented phosphorylation of Akt/PKB and GSK-3 after ionizing radiation and strongly
reduced the accumulation of
p53 ... Correspondingly, down-regulation of
DNA-PK prevented phosphorylation of
Akt/PKB and GSK-3 after ionizing radiation and strongly reduced the accumulation of p53 ... Correspondingly, down-regulation of
DNA-PK prevented phosphorylation of
Akt/PKB and GSK-3 after ionizing radiation and strongly reduced the accumulation of p53
Hill et al., DNA repair 2008
:
Chromium induced apoptosis therefore involves
DNA-PK mediated
p53 activation followed by preferential transcription of pro-apoptotic PUMA over anti-apoptotic p21 genes
Guirouilh-Barbat et al., Mol Biol Cell 2008
:
In contrast to DNA-PK, ATM phosphorylated
H2AX both in NER-proficient and -deficient cells, but its full activation was
dependent on H2AX as well as
DNA-PK , suggesting a positive feedback loop : DNA-PK-gamma-H2AX-ATM. Knocking-out H2AX or inactivating DNA-PK reduced Et743 's antiproliferative activity, whereas ATM and MRN tended to act as survival factors
Huston et al., Proc Natl Acad Sci U S A 2008
:
Intersecting regulatory inputs for cAMP employ EPAC to transduce positive effects, namely the
Rap2 dependent nuclear exit and activation of
DNA-PK , whereas protein kinase A (PKA) provides the negative input by antagonizing these actions
Surucu et al., J Biol Chem 2008
:
However, the physiological
role of
DNA-PK in the regulation of
PKB phosphorylation remains to be established
Dittmann et al., Molecular cancer 2008
:
Radiation induced caveolin-1 associated EGFR internalization is linked with nuclear
EGFR transport and
activation of
DNA-PK ... Radiation induced caveolin-1- and EGFR-phosphorylations were associated with nuclear
EGFR transport and
activation of
DNA-PK , as detected by phosphorylation at T2609
Becher et al., J Child Neurol 2008
(Astrocytoma...) :
IGFBP2 is overexpressed by pediatric malignant astrocytomas and
induces the repair enzyme
DNA-PK
Solier et al., Mol Cell Biol 2009
:
H2AX phosphorylation was dependent on DNA-PK, while
Chk2 phosphorylation was
dependent on both ATM and
DNA-PK ...
H2AX phosphorylation was
dependent on
DNA-PK , while Chk2 phosphorylation was dependent on both ATM and DNA-PK
Durkin et al., J Biol Chem 2008
:
Tax containing nuclear extracts showed increased DNA-PK activity, and specific inhibition of
DNA-PK prevented Tax induced activation of
Chk2 kinase activity ... We also describe a novel interaction between
DNA-PK and Chk2 that
requires Tax
Bozulic et al., Curr Opin Cell Biol 2009
(Neoplasms) :
This present review concerns
PKB regulation by mTORC2 and
DNA-PK in a stimulus dependent and context dependent manner and the possible implications of this for PKB activity, substrate specificity and therapeutic intervention
Ting et al., Nucleic Acids Res 2009
:
Furthermore, we show that
hnRNP A1 is phosphorylated in vivo in a
DNA-PK dependent manner and that this phosphorylation is greatly reduced in cell lines which lack hTR
Mannell et al., Cell Signal 2010
:
The
DNA dependent protein kinase (DNA-PK) , long known for its importance in repairing DNA double strand breaks, belongs to the phosphatidylinositol-3 kinase (PI3-K) super family and has recently been identified as one of the enzymes phosphorylating and
activating Akt
Wang et al., Neoplasia (New York, N.Y.) 2009
:
Specific disruption of
PP2A by either expression of SV40 small tumor antigen or depletion of endogenous PP2A/C by RNA interference
inhibits Ku DNA binding and
DNA-PK activities, which results in suppression of DNA double-strand break ( DSB ) repair and DNA end joining in association with increased genetic instability ( i.e., chromosomal and chromatid breaks ) ... Overexpression of the
PP2A catalytic subunit (PP2A/C) enhances Ku and
DNA-PK activities with accelerated DSB repair
Kanungo et al., Mol Cell Biochem 2010
:
Exogenously expressed human Ku70 stabilizes
Ku80 in Xenopus oocytes and
induces heterologous
DNA-PK catalytic activity ... Exogenously expressed human
Ku70 stabilizes Ku80 in Xenopus oocytes and
induces heterologous
DNA-PK catalytic activity
Sotiropoulou et al., Nat Cell Biol 2010
:
The attenuated
p53 activation is the consequence of a faster DNA repair activity, mediated by a higher non-homologous end joining ( NHEJ ) activity,
induced by the key protein
DNA-PK
Shimura et al., Oncogene 2010
(Neoplasms) :
Acquired radioresistance of human tumor cells by
DNA-PK/AKT/GSK3beta mediated
cyclin D1 overexpression
Zhu et al., PloS one 2010
:
Furthermore, we demonstrated that the expression of Cav-1 protected cells against DNA damage through modulating the activities of both the homologous recombination ( HR ) and non-homologous end joining ( NHEJ ) repair systems, as evidenced by the inhibitory effects of the Cav-1 targeted siRNA on cell survival, HR frequency, phosphorylation of
DNA dependent protein kinase (DNA-PK) , and nuclear translocation of epidermal growth factor receptor (EGFR) following DNA damage, and by the stimulatory
effect of the forced expression of
Cav-1 on NHEJ frequency
Zhang et al., Blood 2011
:
Moreover, increased
AKT ( Ser473 ) phosphorylation was observed in activated B cells, reminiscent of cancers treated with rapamycin, and was
reduced by a
DNA-pk inhibitor
Zhu et al., Cancer Res 2011
(Cell Transformation, Neoplastic) :
RSK2 and
DNA-PK , but not ATM or ATR, are
required for EGF induced phosphorylation of
H2AX at Ser139 ; however, only RSK2 is required for phosphorylation of H2AX at Ser16
Bouquet et al., J Cell Sci 2011
:
Importantly, in using either silenced DNA-PK cells or cells exposed to a specific DNA-PK inhibitor ( NU7026 ), we demonstrated that hypoxic
DNA-PK activation positively
regulates the key transcription factor
HIF-1 and one subsequent target gene, GLUT1 ... Importantly, in using either silenced DNA-PK cells or cells exposed to a specific DNA-PK inhibitor ( NU7026 ), we demonstrated that hypoxic
DNA-PK activation positively
regulates the key transcription factor HIF-1 and one subsequent target gene,
GLUT1
Zhao et al., Mol Endocrinol 2011
(Carcinoma, Hepatocellular...) :
Herein, we demonstrate that the orphan nuclear receptor TR3 suppresses DSB repair by blocking Ku80 DNA-end binding activity and promoting
DNA-PK induced
p53 activity in hepatoma cells ... Phosphorylated TR3, in turn, enhances
DNA-PK induced phosphorylation and
p53 transcription activity, thereby enhancing IR-induced apoptosis in hepatoma cells
Zolner et al., Nucleic Acids Res 2011
:
Ionizing radiation ( IR ) -induced phosphorylation of cellular PNKP on S114 was ATM dependent, whereas phosphorylation of
PNKP on S126
required both ATM and
DNA-PK
Liu et al., Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases 2011
:
To study the
roles of
DNA dependent protein kinase ( DNA-PK ) in silica induced cell cycle changes and expressions of CyclinE and
CDK2 in human embryo lung fibroblasts ( HELF )
Stronach et al., Neoplasia (New York, N.Y.) 2011
(Carcinoma...) :
DNA-PK mediates
AKT activation and apoptosis inhibition in clinically acquired platinum resistance ... Insulin mediated activation of AKT is unaffected by DNA-PK inhibitor treatment, suggesting that this effect is restricted to DNA damage mediated activation of AKT and that, clinically,
DNA-PK inhibition might
prevent platinum induced
AKT activation without interfering with normal glucose homeostasis, an unwanted toxicity of direct AKT inhibitors
Tang et al., Chembiochem 2012
:
Our findings show that nuclear and cytoplasmic Abl kinase is activated early on ( within 5 min ) in response to IR by both ATM and
DNAPK , and that although one or the other of these kinases is required, either one is
sufficient to activate
Abl
Furusawa et al., Cancer Lett 2012
(Leukemia) :
Inhibition of ataxia-telangiectasia mutated (ATM) or DNA-PK revealed that
DNA-PK , rather than ATM, was preferentially
involved in
Akt phosphorylation and cell survival after US-exposure in all cell lines
Williamson et al., EMBO Mol Med 2012
(Disease Models, Animal...) :
In ATM-deficient MCL cells, olaparib induced
DNA-PK dependent phosphorylation and stabilization of
p53 as well as expression of p53-responsive cell cycle checkpoint regulators, and inhibition of DNA-PK reduced the toxicity of olaparib in ATM-deficient MCL cells
Solier et al., Proc Natl Acad Sci U S A 2012
:
We also show that DNA-PK is a client of HSP90a and that
HSP90a is
required for full
DNA-PK activation, ?-H2AX formation, DNA fragmentation, and apoptotic body formation ... We also show that
DNA-PK is a client of HSP90a and that HSP90a is
required for full DNA-PK activation,
?-H2AX formation, DNA fragmentation, and apoptotic body formation ... In contrast,
HSP90 inhibition by geldanamycin markedly
enhances TRAIL induced
DNA-PK and H2AX activation ... In contrast, HSP90 inhibition by geldanamycin markedly enhances
TRAIL induced
DNA-PK and H2AX activation
Baritaud et al., Cell death & disease 2012
:
AIF mediated caspase independent necroptosis requires ATM and
DNA-PK induced
histone H2AX Ser139 phosphorylation ... Employing a pharmacological approach and gene knockout cells, we also demonstrate in this paper that the phosphatidylinositol-3-OH kinase related kinases ( PIKKs ) ATM ( ataxia telangiectasia mutated ) and
DNA dependent protein kinase (DNA-PK) mediate
?H2AX generation and, consequently, MNNG induced necroptosis ... Further,
DNA-PK contributes to
H2AX Ser139 phosphorylation
Liu et al., Nucleic Acids Res 2012
:
Distinct
roles for
DNA-PK , ATM and ATR in
RPA phosphorylation and checkpoint activation in response to replication stress
Urushihara et al., Biochem Biophys Res Commun 2012
:
DNA-PK inhibition
causes a low level of
H2AX phosphorylation and homologous recombination repair in Medaka ( Oryzias latipes ) cells
Wang et al., Mol Cell Biol 2013
:
Thus, centrosomal
DNA-PK signaling triggers centrosome overduplication, and this centrosomal event, but not the nuclear DNA damage response, is
controlled by
SF-1
Ito et al., PloS one 2012
:
The results of an in vitro kinase assay showed that
BPA inhibited
DNA-PK kinase activity in a concentration dependent manner
Ferguson et al., eLife 2012
:
DNA-PK has well established functions in the DNA repair and V ( D ) J recombination, hence loss of
DNA-PK leads to
severe combined immunodeficiency (SCID)
Shimura et al., Cell cycle (Georgetown, Tex.) 2013
:
We recently demonstrated that a moderate level of long-term fractionated radiation confers acquired radioresistance to tumor cells, which is caused by
DNA-PK/AKT/GSK3ß mediated
cyclin D1 overexpression
Li et al., J Biol Chem 2013
:
The current study has uncovered a previously unknown mechanism underlying rapamycin induced Akt phosphorylation involving protein
phosphatase 2A (PP2A) dependent
DNA protein kinase (DNA-PK) activation ... Chemical inhibition of
DNA-PK , knockdown or deficiency of DNA-PK catalytic subunit (DNA-PKcs), or knock-out of the DNA-PK component Ku86
inhibited rapamycin induced
Akt phosphorylation ... Exposure of cancer cells to rapamycin increased
DNA-PK activity, and gene silencing mediated
PP2A inhibition attenuated rapamycin induced DNA-PK activity ... Accordingly, simultaneous inhibition of mTOR and
DNA-PK did not
stimulate Akt activity and synergistically inhibited the growth of cancer cells both in vitro and in vivo
Zhang et al., Invest Ophthalmol Vis Sci 2013
:
Our findings suggest Compound 49b
induces DNA-PK levels through
PKA activity ...
DNA-PK is
required for Compound 49b induced
IGFBP-3 expression, leading to inhibition of REC cell death
Meyer et al., Nucleic Acids Res 2013
:
Clustered DNA damage induces pan-nuclear
H2AX phosphorylation
mediated by ATM and
DNA-PK
Calkins et al., Nucleic Acids Res 2013
:
Loss of DNA-PK function prevented activation of PARP-1 and its recruitment to chromatin in damaged cells, suggesting
regulation of
PARP-1 by
DNA-PK within a pathway of DNA repair
Brush et al., Proc Natl Acad Sci U S A 1994
:
Studies with the simian virus 40 model system indicate that
DNA-PK is
required for DNA-replication dependent
RPA phosphorylation
Watanabe et al., Biochem Biophys Res Commun 1994
:
DNA-PK activity determined with a synthetic peptide and alpha-casein as substrates was
stimulated several-fold by
HMG1 , HMG2, and the DNA binding domains ...
DNA-PK activity determined with a synthetic peptide and alpha-casein as substrates was
stimulated several-fold by HMG1,
HMG2 , and the DNA binding domains ... The stimulation was decreased at higher concentrations of HMG proteins, and
DNA-PK activity was
inhibited by
histone H1
An et al., Biochem Biophys Res Commun 1994
:
The ability of
p41 to
inhibit DNA-PK was largely abolished by heating at 95 degrees C for 30 min
Lees-Miller et al., J Virol 1996
:
As ICP0 acts as a promoter independent transactivator of gene expression, these data suggest that ICP0 may function by directly or indirectly targeting the p350/DNA-PKcs subunit of DNA-PK, thereby altering the inhibitory
effects of
DNA-PK on
RNA polymerase II transcription
Kharbanda et al., Nature 1997
:
We show that
DNA-PK phosphorylates and
activates c-Abl in vitro
Chibazakura et al., Eur J Biochem 1997
:
These observations suggest that
DNA-PK could positively
regulate the Pol II basal transcription by phosphorylating
TBP and TFIIB
Chen et al., Mutat Res 1997
:
Analysis of V3, a hamster equivalent of SCID, indicates that the protein level increases of
RAD51 and RAD52 from G0 to G1/S/G2 do not
require DNA-PK ... Analysis of V3, a hamster equivalent of SCID, indicates that the protein level increases of RAD51 and
RAD52 from G0 to G1/S/G2 do not
require DNA-PK
Jin et al., EMBO J 1997
:
The propensity for Ku70 to associate with Ku80 and to bind DNA correlates with the ability to activate DNA-PK, although two mutants showed that the
roles of
Ku70 in
DNA-PK activation and IR repair are separate
Mayo et al., Cancer Res 1997
:
The data support a model by which
DNA-PK activation by DNA damage and phosphorylation of
Mdm-2 renders the Mdm-2 protein unable to inhibit p53 transactivation, resulting in cell cycle arrest
Bandyopadhyay et al., J Biol Chem 1998
:
Anti-EGFR mAb induced physical interaction between EGFR and
DNA-PK or Ku70/80 was
dependent on the presence of EGFR, but not on the levels of
EGFR ... Our findings demonstrate the existence of a novel cellular pathway in mammalian cells that involves physical interactions between EGFR and
DNA-PK or Ku70/80 in
response to inhibition of
EGFR signaling
Leber et al., J Biol Chem 1998
:
Both
DNA-PK dependent and independent phosphorylation of
XRCC4 in vitro occurs only on serine and threonine residues within the COOH-terminal 130 amino acids, a region of the molecule that is not absolutely required for XRCC4 's DSBR function
Candéias et al., Biochimie 1997
:
Thus, our results show that
DNA-PK is not the main sensor for genotoxic stress and is not
required for
p53 activation ... In fact, they rather suggest that
DNA-PK may
play a role in
p53 down-regulation
Kharbanda et al., Oncogene 1998
:
The
DNA dependent protein kinase (DNA-PK) and the ataxia telangiectasia mutated (ATM) gene product, effectors in the DNA damage response,
contribute to the induction of
c-Abl activity
Ruscetti et al., J Biol Chem 1998
:
The protein kinase activity of
DNA-PK can be
stimulated by
PARP in the presence of NAD+ in a reaction that is blocked by the PARP inhibitor 1, 5-dihydroxyisoquinoline
Basu et al., Biochem Biophys Res Commun 1998
(Glioma) :
The
role of
DNA-PK , a protein kinase involved in the response to DNA damage, in the activation of NF kappa B by IR and
TNF alpha was examined ... The
role of
DNA-PK , a protein kinase involved in the response to DNA damage, in the activation of
NF kappa B by IR and TNF alpha was examined ... In HeLa cells, wortmannin, an inhibitor of
DNA-PK ,
blocked the induction of
NF kappa B by IR but not by TNF alpha
Woo et al., Nature 1998
:
We find that p53 is incapable of binding to DNA in the absence of DNA-PK, that
DNA-PK is
necessary but not sufficient for activation of
p53 sequence-specific DNA binding, and that this activation occurs in response to DNA damage
Yumoto et al., J Biochem 1998
:
We previously reported that the activity of
DNA-PK in vitro is
stimulated by non-histone chromosomal
high mobility group proteins (HMG) 1 and 2 comprising two similar repeats, termed domains A and B, and an acidic C-terminal
Kharbanda et al., Oncogene 1998
:
c-Abl associates with the DNA dependent protein kinase (DNA-PK) and is
activated by
DNA-PK dependent phosphorylation